The key results presented here demonstrate that the macrophage-derived inflammatory mediator IL-1β potentiates the hepatic manifestation of the metabolic syndrome by stimulating lipogenesis and hepatic steatosis in obese mice (Figs. 5–7). This evidence concerns the gene IL1B and Hepatic steatosis.